Company news
Ondine Biomedical, Inc. (LSE:OBI) news
Ondine Biomedical, Inc. news releases on 6ix. Latest, Sep 30, 2026: Capital Access Window - Ondine Biomedical Inc.
Press releases & updates
Capital Access Window - Ondine Biomedical Inc.
September 30, 2026
Capital Access Window
September 30, 2026
2026 Interim Results & Post-Period Momentum
September 30, 2026
Ondine and Mela Advance NHS ICU Market Access
September 29, 2026
Steriwave Deploys in 5 Southern Ontario Hospitals
September 23, 2026
Investor Presentation of Phase 3 Topline Results
September 10, 2026
Largest Private Mexican Network Pilots Steriwave
September 7, 2026
Notification of major holdings
September 4, 2026
Positive Topline Results in US Phase 3 Study
September 1, 2026
Major Scottish Hospital Adopts Steriwave
July 30, 2026
Keynote Address at 8th Annual Photodynamic Day
July 1, 2026
Leeds drops SSI 78% over Mupirocin with Steriwave
June 30, 2026
Update on US Phase 3 Pivotal Study
June 22, 2026
Leeds Drops SSIs by 78.5% in Complex Brain Surgery
June 18, 2026
Grant of Options and RSUs, and Issue of Warrants
June 8, 2026
2025 Full Year Results and Annual Report
June 4, 2026
Steriwave ICU Study Outcomes Presented at CSRT2026
May 26, 2026
Notification of major holdings - hInsight-NX, LLC
May 6, 2026
Ondine Presented Steriwave Data at IPC 2026
April 30, 2026
Proposed c.£5 million (C$9.23 million) Fundraise
April 28, 2026
ICU Study to be Presented at 2026 CACCN Conference
April 27, 2026
Marked Reduction in SSIs at Ottawa Heart Institute
April 23, 2026
Two Abstracts Accepted at World Congress
April 22, 2026
Steriwave ICU Study Shows 39.5% Pneumonia Drop
April 14, 2026
Business Update
April 13, 2026
ICU Study Accepted for Publication
April 8, 2026
Holdings in Company
March 24, 2026
Ondine Provides Update on US Phase 3 Pivotal Study
March 10, 2026
Share Issuance for ICU Study Submission
February 25, 2026
Holding(s) in Company
February 20, 2026
Ondine and Mid Yorks Win National Award
February 6, 2026
Steriwave Up for 2025 “Product of the Year” Award
February 2, 2026
Expanding Steriwave Use Across Vancouver Island
January 27, 2026
Steriwave Expands into ENT Surgery in Spain
January 22, 2026
New Independent Study Supports Photodisinfection
January 13, 2026
Finalist for 2nd National Award for SSI reduction
December 23, 2025
First German Hospital Pilots Steriwave
December 22, 2025
Ondine shortlisted for HSJ Partnership Award
December 16, 2025
Topline Results Significant in Steriwave ICU Study
October 27, 2025
Cambridge’s Papworth Hospital Pilots Steriwave
October 2, 2025
Ondine Biomedical Continues Growth in H1 2025
September 26, 2025
Steriwave Now Protecting Patients with Cancer
September 23, 2025
Notice of Interim Results & Investor Presentation
September 19, 2025
Ondine Presents Major Economic Benefits at ICPIC
September 18, 2025
Steriwave proven to be effective against C Auris
September 15, 2025
Grant of Options
September 12, 2025
Steriwave Featured on CNBC’s Worldwide Exchange
September 10, 2025
Notification of major holdings - hInsight
September 8, 2025
Notification of major holdings - Pentwater
September 4, 2025
Ondine to present Health Economic Data at ICPIC
September 3, 2025